Europe’s Life Science Strategy: Strengthening Health Industries and their Workforces
The European Commission has launched a new Strategy for European Life Sciences, aiming to position the EU as the world's most attractive hub for life sciences by 2030. With healthcare and biotechnology playing a critical role in population well-being and economic resilience, the strategy outlines bold steps to drive innovation, tackle structural barriers, and equip Europe’s workforce and life science companies for the future.
A Strategic Priority for Europe’s Future
Europe’s life sciences sector is one of the continent's most vital industries, both economically and socially. It employs around 29 million people and includes some of the world’s leading companies in health-related research and innovation.
The sector contributes to:
Currently, Europe hosts 15% of the world’s top life sciences firms in terms of R&I investment. Employment in biotechnology is growing six times faster than the overall EU economy.
Barriers to Innovation and Competitiveness
Despite its strengths, Europe is facing major structural challenges in turning scientific research into market-ready solutions. The EU is losing ground to global competitors such as the USA and China, particularly in biotech patenting and innovation scale-up.
Key challenges include:
These issues pose a risk to Europe’s competitiveness in critical areas such as medical devices, clinical research, and biotechnology.
EU Policy Response: Strengthening Innovation and Scale-Up
To address these challenges, the European Commission plans to:
As the strategy highlights:
“It is critical to ensure the EU’s health security and autonomy as geopolitical challenges increase.”
Building a Future-Ready Workforce
From AI to digitalisation and from genetics and genomics to biochemistry, workers provide core scientific knowledge from human health to industrial processes to biotechnology industries. A robust and skilled workforce is essential to deliver on Europe’s life sciences ambitions. With ageing populations, rising healthcare costs, and a need for stronger preventative systems, talent development is more important than ever.
However, the sector faces growing workforce and career challenges:
To address these issues, the EU will:
Promoting Trust and Tackling Disinformation
As the life sciences sector continues to evolve, the Commission also emphasises the importance of building public trust. This involves working more closely with patients and end-users to ensure solutions meet real-world needs, while also combating disinformation related to health and science.
BRIGHTskills: Supporting the Strategy Through Workforce Innovation
Aligned with the EU’s vision, the BRIGHTskills Project is focused on strengthening the life sciences workforce to enhance competitiveness and innovation. Its key contributions include:
BRIGHTskills is a practical step toward ensuring that today’s workforce is ready to meet the healthcare challenges of tomorrow.
👉 Get involved to help shape the future of health innovation in Europe—and ensure the next generation of scientists, engineers, and entrepreneurs are prepared to lead.